Medical Bulletin 29/April/2023

A procedure that uses controlled electrical pulses to induce changes to the lining of the first part of the small intestine could allow patients with Type 2 diabetes to stop taking insulin and still maintain glycemic control, according to a preliminary first-in-human study that will be presented at Digestive Disease Week® (DDW) 2023.

Reference:

Celine Busch et al,DIGESTIVE DISEASE WEEK

Risk of obesity-related cancers cut by more than half by bariatric surgery: Study

Bariatric surgery involves making changes to the digestive system to help a person lose weight.

Just 4% of patients with obesity who underwent bariatric surgery developed obesity-associated cancer in a 10-year follow up, compared to 8.9% among those who did not have a weight-loss procedure, according to a study to be presented at Digestive Disease Week® (DDW) 2023.

"The primary benefit people consider when they think about bariatric surgery is weight loss and the accompanying physical and psychological benefits, such as improved blood pressure and diabetes,” said Dr. Vibhu Chittajallu, the study’s lead author and a gastroenterology fellow at Case Western Reserve University and University Hospitals. “This study adds to the building evidence that the significant weight loss associated with bariatric surgery may have a protective effect against cancer formation as well.”

Reference:

Dr. Vibhu Chittajallu et al, “Bariatric surgery decreases the risk of developing cancer: a multicenter population-based study,” ,DIGESTIVE DISEASE WEEK